您当前所在位置:首页 > 资讯信息 > 新品上市
基于DSPE-PEG-Paclitaxel构建的紫杉醇微乳制剂的制备
发布时间:2025-06-24     作者:zyl   分享到:

文献:Research on paclitaxel microemulsion

文献链接:https://xueshu.baidu.com/usercenter/paper/show?paperid=711ecf9ab37cd13cc80ce6b099adfed6&site=xueshu_se

作者:阎家麒,王惠杰,童岩,臧莹安,王九一

摘要:

OBJECTIVE:To study the preparation of microemulsion containing paclitaxel for both intravenous and oral administration,its stability and bioavailability. METHODS:Corn oil was hydrated and sonicated.EPC,paclitaxel and PEG-DSPE were combined in CHCl-3.A thick lipid film was obtained after drying under a stream of N-2 and vacuum evacuation.The hydrated oil was added directly to the thin phospholipid film,vortexed and then sonicated.The mixture was passed through the Microfluidizer for microemulsified. RESULTS:The particle size was 50~100 nm,the encapsulation efficiency was ≥99.2% and the absolute bioavailability of intravenous and oral adminstration was 107.7% and 22.4%,respectively. CONCLUSION:This study developed a new formulation for paclitaxel.

DSPE-PEG-Paclitaxel

目的:研究紫杉醇静脉和口服微乳的制备、稳定性和生物利用度。

方法:将玉米油水合并超声处理。EPC、紫杉醇和PEG-DSPE在CHCl-3中混合。在N-2流和真空抽空下干燥后获得厚脂质膜。将水合油直接加入薄磷脂膜中,涡旋,然后超声处理。将混合物通过微流化器进行微乳化。

结果:粒径为50~100nm,包封率≥99.2%,静脉和口服给药的绝对生物利用度分别为107.7%和22.4%。

结论:本研究开发了一种新的紫杉醇制剂。

相关推荐:

DSPE-PEG-Cy5.5

DSPE-PEG-Cy7

DSPE-PEG-NBD

DSPE-PEG-TRITC

DSPE-PEG-Comarin

DSPE-PEG-ICG

DSPE-PEG-Pyrene

DSPE-PEG-Ce6

版权声明:

本平台根据相关科技期刊文献、教材以及网站编译整理的内容,仅用于对相关科学作品的介绍、评论以及课堂教学或科学研究。如有侵权,请联系我们删除。


库存查询